α-LGR5 was extensively validated for a variety of research applications and detects cancer types with high levels of LGR5 (LGR5+ cells) - CRC (>80% of cases) and HCC (>90% of cases)—relative to healthy tissues that express low levels of the protein. This evidence concerns the gene LGR5 and hepatocellular carcinoma.